In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...
The Central Drugs Standard Control Organisation (CDSCO) has launched a new risk classification module on the drug regulator's online system for medical devices in order to simplify the regulatory ...
A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...
At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but ...
Ryan Wedding rose to fame as a Canadian Olympic athlete, but the authorities say he became one of the world’s biggest drug ...
Slingshot News on MSNOpinion
'It's barely covered': Clueless Trump scratches his head wondering why no one cares about him 'reducing' drug prices by 2,000%
Donald Trump made an appearance at Mar-a-Lago last week to announce a "Golden Fleet" of Trump-class battleships. During Q&A ...
Numerous recalls have been issued due to potential damage, foodborne illness, contamination and undeclared food allergens.
IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has provided an announcement. IRLAB Therapeutics has obtained regulatory and ethical approval to ...
Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
President Donald Trump signed an executive order Dec. 18 calling on federal officials to finish reclassifying marijuana as a less dangerous drug — a major shift in federal drug policy that could […] ...
The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback